Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Australia.
School of Chemical Engineering and Advanced Materials, The University of Adelaide, Adelaide, Australia.
J Colloid Interface Sci. 2022 Oct 15;624:242-250. doi: 10.1016/j.jcis.2022.05.099. Epub 2022 May 18.
Förster resonance energy transfer (FRET) has been widely used for monitoring drug release from nanoparticles (NPs). To understand the drug release from bioinspired drug-core silica-shell NPs, we synthesised two types of NPs using the dual-functional peptide SurSi via biosilicification for the first time, i.e., silica NP conjugated with FRET (Cy3 and Cy5) molecules, and FRET-core (DiO and DiI) silica-shell NP with different shell thicknesses (18 and 41 nm). The release kinetics of these two types of NPs were investigated under different conditions, including fetal bovine serum (FBS) and in cells, to mimic the drug release during blood circulation and intracellularly. Two different drug release mechanisms were identified. Cargo diffusion dominated the release during circulation, while the degradation of silica shell played a key role in drug release intracellularly.
Förster 共振能量转移 (FRET) 已广泛用于监测纳米粒子 (NPs) 中药物的释放。为了了解仿生药物核心-硅壳 NPs 中的药物释放情况,我们首次使用双功能肽 SurSi 通过生物矿化合成了两种 NPs,即与 FRET(Cy3 和 Cy5)分子偶联的硅纳米粒子和具有不同壳厚度 (18 和 41nm) 的 FRET-核心(DiO 和 DiI)硅壳 NP。研究了这两种 NPs 在不同条件下(包括胎牛血清 (FBS) 和细胞内)的释放动力学,以模拟血液循环和细胞内药物释放情况。确定了两种不同的药物释放机制。载体扩散在循环过程中主导了释放,而硅壳的降解在细胞内药物释放中起着关键作用。